Investors

Webcast ImageWebcast
Coherus Biosciences Inc. at Cowen and Company 37th Annual Health Care Conference  (Live)
03/06/17 at 4:40 p.m. ET
Coherus Biosciences Inc. at Cowen and Company 37th Annual Health Care Conference
Monday, March 6, 2017 4:40 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast
Coherus Biosciences Inc at Barclays Global Healthcare Conference 2017 (Live)
03/15/17 at 9:30 a.m. ET
Coherus Biosciences Inc at Barclays Global Healthcare Conference 2017
Wednesday, March 15, 2017 9:30 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast
Q4 2016 Coherus Biosciences Inc Earnings Conference Call (Live)
03/13/17 at 4:30 p.m. ET
Q4 2016 Coherus Biosciences Inc Earnings Conference Call
Monday, March 13, 2017 4:30 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar

Overview

Coherus is a late-stage biologics platform company focused on the global biosimilar market. Headquartered in the San Francisco Bay Area and composed of a team of industry veterans with decades of experience in pioneering biologics companies, our goal is to become a global leader in the biosimilar market by leveraging our team’s collective expertise in key areas such as process science, analytical characterization, protein production and clinical-regulatory development. Our commercialization partnerships include global pharmaceutical companies in Europe, Asia and Latin America.

Recent News

DateTitle
02/21/17Coherus BioSciences to Report Fourth Quarter and Full Year 2016 Financial Results on March 13th
REDWOOD CITY, Calif., Feb. 21, 2017 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq:CHRS), today announced that its fourth quarter and full year 2016 financial results will be released after market close on Monday, March 13, 2017.  At 4:30 p.m. Eastern Time, Coherus’ management will host a conference call to discuss the financial results and provide a general business update.   After releasing fourth quarter and full year 2016 financial results, we will post them on the Coherus BioSci... 
02/17/17Coherus BioSciences Announces New Employment Inducement Grants
REDWOOD CITY, Calif., Feb. 17, 2017 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq:CHRS), today announced that effective February 16, 2016, the compensation committee of the company’s board of directors granted 6 new employees options to purchase an aggregate of 155,000 shares of the company’s common stock with a per share exercise price of $23.00, the closing trading price on the grant date.  In addition, options to purchase 45,000 shares of common stock were granted to a Vice Presiden... 
02/08/17Coherus Prices Public Offering of Common Stock
REDWOOD CITY, Calif., Feb. 08, 2017 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq:CHRS) today announced the pricing of its underwritten public offering of 5,154,640 shares of its common stock at a price to the public of $24.25 per share. All of the shares of the common stock to be sold in the offering will be offered by Coherus. In addition, Coherus has granted the underwriters a 30-day option to purchase up to an additional 773,196 shares of its common stock at the public offering pri... 
02/07/17Coherus Announces Proposed Public Offering of Common Stock
REDWOOD CITY, Calif., Feb. 07, 2017 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq:CHRS), today announced it has commenced an underwritten public offering of $125,000,000 of shares of its common stock. All of the shares of the common stock to be sold in the offering will be offered by Coherus. In addition, Coherus expects to grant the underwriters a 30-day option to purchase up to an additional $18,750,000 of shares of its common stock at the public offering price, less the underwriting... 
View All

Receive E-mail Alerts

Sign up to receive e-mail alerts whenever Coherus Biosciences Inc posts new information to the site. Just enter your e-mail address and click Submit.
 

CHRS (Common Stock)

ExchangeNASDAQ (US Dollar)
Price$21.75
Change (%) Stock is Up 0.10 (0.46%)
Volume242,314
Data as of 02/24/17 4:00 p.m. ET
Refresh quote
Data provided by Nasdaq. Minimum 15 minutes delayed.
Print PagePrint Page
E-mail PageE-mail Page
RSS FeedsRSS Feeds
E-mail AlertsE-mail Alerts
Financial Tear SheetFinancial Tear Sheet